541.527.1800 contact@TriAgenics.com

Wisdom Teeth Treatment Options & Outcomes

Comparison of Costs, Risks and Outcomes

Once FDA approved, 3TBA is expected to be the lowest risk procedure while also having the lowest total-treatment cost and best lifelong outcomes.

*Projected. Includes all exam, x-ray imaging, sedation, procedure fees and costs associated with treating complications and lifelong chronic conditions following treatment. As demonstrated in animal studies. Not approved for human clinical use. All values above includes exam, x-ray imaging, sedation, procedure fees and costs associated with treating complications and lifelong chronic conditions following treatment.

1 Friedman, J. The Case Against Prophylactic Third Molar Extractions 2012 National Oral Health Conference; May 2012; http://www.nationaloralhealthconference.com/docs/presentations/2012/05-02/Jay%20Friedman.pdf
2 Koumaras, G.M. What Costs Are Associated With the Management of Third Molars? Proceedings From The Third Molar Multidisciplinary Conference, J. Oral & Maxillofacial Surgery, Volume 70, Number 9, Supplement 1, Sept. 2012, p S8-S10.

Pro Forma Website

This is a pro forma website based solely upon animal study data. TriAgenics’ Zero3™ 3TBA procedure is not approved for human use.